Morgan Stanley’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Morgan Stanley’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35,631	Closed	-$374K	–	8172
2022 Q3	$374K	Buy	35,631 +3,524	+11%	+$36.9K	﹤0.01%	5420
2022 Q2	$333K	Sell	32,107 -77,096	-71%	-$478K	﹤0.01%	5630
2022 Q1	$714K	Sell	109,203 -45,076	-29%	-$297K	﹤0.01%	5192
2021 Q4	$1.29M	Buy	154,279 +153,555	+21,209%	+$1.13M	﹤0.01%	4899
2021 Q3	$6K	Sell	724 -9,129	-93%	-$81.3K	﹤0.01%	7465
2021 Q2	$112K	Buy	+9,853	New	+$114K	﹤0.01%	6305

Morgan Stanley's CNVY Position: Q4 2022 in Review

Morgan Stanley sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q4 2022, closing a stake of 35,631 shares — an estimated $374K sold.

Morgan Stanley first reported a position in CNVY in Q2 2021 and held it in 6 quarters. The position peaked at $1.29M in Q4 2021. 0 funds tracked by Wall St. Rank hold CNVY as of Q4 2022.

Morgan Stanley reported no remaining Convey Health Solutions Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
Morgan Stanley sold 35,631 Convey Health Solutions Holdings, Inc. shares in Q4 2022, an estimated $374K.
Morgan Stanley first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 6 quarters.
Morgan Stanley's Convey Health Solutions Holdings, Inc. position peaked at $1.29M in Q4 2021.
0 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.